Stepan Co.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: US8585861003
USD
45.01
-0.89 (-1.94%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Stepan Co. stock-summary
stock-summary
Stepan Co.
Specialty Chemicals
Stepan Company produces specialty and intermediate chemicals. It operates through three segments: Surfactants, Polymers and Specialty Products. Surfactants segment offers products, which are principal ingredients in consumer and industrial cleaning products, such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos and body washes. Other applications of Surfactants include fabric softeners, lubricating ingredients, emulsifiers for spreading agricultural products and industrial applications, such as latex systems and composites. Polymers include polyurethane polyols, polyester resins and phthalic anhydride. Polyurethane polyols are used in the manufacture of rigid foam for thermal insulation in the construction industry and are also a base raw material for coatings, adhesives, sealants and elastomers. Specialty Products include flavors, emulsifiers and solubilizers used in food, flavoring, nutritional supplement and pharmaceutical applications.
Company Coordinates stock-summary
Company Details
Edens & Winnetka Road , NORTHFIELD IL : 60093
stock-summary
Tel: 1 847 44675001 847 4467500
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 61 Schemes (46.77%)

Foreign Institutions

Held by 94 Foreign Institutions (5.51%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Frank Stepan
Chairman of the Board, Chief Executive Officer
Mr. Edward Wehmer
Lead Independent Director
Mr. Michael Boyce
Independent Director
Mr. Randall Dearth
Independent Director
Dr. Joaquin Delgado
Independent Director
Mr. Gregory Lawton
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
595 Million
(Quarterly Results - Jun 2025)
Net Profit:
11 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 1,349 Million (Small Cap)

stock-summary
P/E

26.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.56%

stock-summary
Debt Equity

0.47

stock-summary
Return on Equity

4.67%

stock-summary
Price to Book

1.09